Interventional/Surgery

Clinical cardiology

Antiplatelet Therapy: When the Evidence Meets the Experience

Oct 1, 2008 10:15 EDT

The optimal management of patients with ACS is an ever-evolving process; clinical experience and practice often outpace guidelines. Watch Drs Bohm, Camm, Fox, Mehta, and Connolly address the state-of-the-art management of ACS and the role of antiplatelets in ACS and beyond.

Interventional/Surgery

PCI vs CABG in Multivessel Disease

Sep 19, 2008 15:00 EDT

As the COURAGE debate rages on, PCI and DES next tackle bypass surgery in patients with diabetes, multivessel disease and left main lesions. From ESC in Munich, Dr Boden joins SYNTAX investigators Drs Mohr and Serruys to discuss PCI and CABG in complex patients given the SYNTAX findings.

Interventional/Surgery

The Management of Multivessel Lesions: Expert Panel Discussion

1 COMMENT - Sep 15, 2008 16:00 EDT

What's the latest on the use of drug-eluting stents in "complex" patients? Join our international panel of experts, Drs Feldman, Kappetein, Mack, and Morice as they discuss the challenges of treating patients with complex lesions - what evidence do we have now and what can we expect to see in the near future?

Acute Coronary Syndrome

The FellowShip series: What is a bleed and what does it mean in clinical practice?

Sep 9, 2008 17:00 EDT

Bleeding in ACS patients has been associated with increased adverse cardiac events and negative patient outcomes. Join Drs Gilles Montalescot and Johanne Silvain as they discuss a case of bleeding and review treatment strategies to improve outcomes and minimize adverse events for these patients.

Interventional/Surgery

COURAGE Quality of Life: How to Manage Patients With Stable Angina

6 COMMENTS - Aug 29, 2008 14:08 EDT

Just when you thought it was safe to go back into the cath lab, COURAGE roars again. In light of quality of life data showing that the early benefits for PCI are lost at two to three years, Drs Kandzari and Popma discuss how to optimally manage patients with stable angina.

Interventional/Surgery

PCI Latin Style

3 COMMENTS - Aug 22, 2008 11:00 EDT

Traditionally, Latin American countries have had lower rates of PCI and DES use compared with Europe and the US. Recorded at SOLACI 2008, Dr Leon leads an information exchange on PCI north and south of the border with Drs Abizaid, Belardi, Echeverri and Lopez-Cuellar.

Clinical cardiology

Thienopyridines in PCI: The lowdown on loading doses

Jun 23, 2008 11:00 EDT

Current guidelines for thienopyridines in PCI note the lack of RCT data for higher loading doses. Read Dr Wang's lowdown on loading doses, including recent presentations from the 2008 SCAI-ACCi2 meeting. Then watch Drs Mehta and Mehran discuss where CURRENT-OASIS-7 will fit in.

Interventional/Surgery

Percutaneous treatment of valvular disease

4 COMMENTS - Jun 4, 2008 13:00 EDT

Given the success of PCI, the transcatheter management of cardiac disease has expanded into new frontiers. The area of valvular intervention has rapidly evolved in recent years. Dr Philipp Bonhoeffer, a pioneer in the field, discusses current and future developments in the percutaneous management of valvular disease.

Interventional/Surgery

DES & PCI: The comeback kids

4 COMMENTS - May 28, 2008 10:00 EDT

In March 2008, USA Today proclaimed that "Angioplasty's golden era may be fading." Not so fast, say interventional cardiologists in light of positive data for DES vs BMS, and the efficacy of PCI in complex settings. Drs Hamm, Rothman and Waksman discuss the state of DES/PCI in the US and Europe.

Interventional/Surgery

The economics of DES vs BMS: Balancing restenosis, stent thrombosis and quality of life

May 7, 2008 15:00 EDT

The incremental cost of DES versus BMS is balanced by reduced restenosis and improved quality of life. What level of stent thrombosis tips the scale back in favor of BMS? Join Drs Cohen and Bhatt as they discuss decision analysis data that tackles these questions.

Interventional/Surgery

Update on bioabsorbable stents from ACC 2008

1 COMMENT - Apr 21, 2008 16:20 EDT

Now you see it, now you don't. Could bioabsorbable stents be the answer to late stent thrombosis or will acute recoil and restenosis prove to be their Achilles heel? Eric Topol reviews the data on the bioabsorbable stents in development and gives his opinion on the likelihood of the disappearing stent becoming a reality.

Interventional/Surgery

The FellowShip Series: Late stent thrombosis - a case study panel discussion

4 COMMENTS - Apr 14, 2008 17:30 EDT

Dr Topol leads a case-study based discussion with three Fellows on late stent thrombosis.

Interventional/Surgery

Decision 2008: The art and science of DES

Apr 14, 2008 10:00 EDT

Join Dr Gregg Stone as he presents the most comprehensive DES/BMS meta-analysis ever! Expert faculty Drs Hermiller, Moses, Popma and Turco also debate current DES safety and efficacy data.

Clinical cardiology

Lost in translation: US and European guidelines for the pharmacologic management of ACS

5 COMMENTS - Apr 10, 2008 14:00 EDT

If we're all looking at the same data, why do the European and US guidelines for the treatment of ACS differ in terms of initiation, dosing, and choices of pharmacological therapies? Drs Ohman, Montalescot, Pollack and Fox discuss the similarities and differences.

Interventional/Surgery

SCAI-ACCi2 2008: What's hot in interventional cardiology?

Apr 9, 2008 09:00 EDT

One year post COURAGE, what's hot in the world of interventional cardiology? Dr Jeffrey Popma gives his take on the top stories from the 2008 ACC and SCAI-ACCi2 scientific sessions.

Interventional/Surgery

Challenging cases: Lower limb intervention

Mar 27, 2008 11:13 EDT

Dr Alan Lumsden walks us through a lower limb percutaneous revascularization procedure, pointing out technical tips and common pitfalls along the way.

Interventional/Surgery

DES 2008: New choices, new era

Jan 21, 2008 12:00 EST

2008 will bring two new DES to the US market. Combined with recent reassuring data on long-term outcomes, will next-generation devices kick-start a comeback for DES? Drs Topol and Teirstein discuss these issues and make predictions for PCI in 2008.

Clinical cardiology

Recent clinical trial data on adjunctive pharmacology in ACS patients undergoing PCI

Dec 27, 2007 12:30 EST

What is the future of adjunctive pharmacology given the results of the HORIZONS and TRITON trials?

Interventional/Surgery

Challenging Cases: Proximal Tortuosity

Dec 21, 2007 15:00 EST

Watch Ashwin Mehta MD navigate hairpin bends in a challenging case of proximal tortuosity.

Clinical cardiology

Risk/benefit or benefit/risk: Trading safety for efficacy with antiplatelet agents

1 COMMENT - Dec 20, 2007 18:00 EST

Trading safety for efficacy with antiplatelet agents

Interventional/Surgery

Optimizing patient outcomes in CAD: Untangling recent drug eluting stent, antiplatelet & medical therapy trial data

Nov 14, 2007 09:30 EST

Over the past year, much debate has been given to the issue of drug-eluting stents (DES) and the risk of restenosis. Trials like COURAGE enrolled patients with chronic stable angina and looked to examine optimal medical therapy versus an invasive strategy. Despite much lively discussion surrounding the results of COURAGE, questions still linger regarding the use of invasive (DES or BMS) versus OMT and what treatment is best for patients with coronary heart disease. This program addresses these issues in an evidence-based manner. Please join Drs Feldman, Kereiakes, Davidson and Farkouh as they untangle recent clinical trial data.

Interventional/Surgery

Paving the road to better outcomes: DES safety

Nov 8, 2007 09:40 EST

Does the search for a "safer" stent minimize the need for a more "efficacious" one? Does increasing safety heighten efficacy? Will stent safety be enhanced by longer duration of antiplatelet therapy? Join our esteemed faculty as they debate these questions.

Interventional/Surgery

Coronary and peripheral revascularization: Is there room in the sandbox for everyone?

Oct 30, 2007 12:00 EDT

Who should be receiving coronary PCI? Who should be performing PCI? What are the best strategies - for doctor and patient - regarding management of peripheral arterial occlusions? Join our faculty for a stimulating and thought-provoking conversation regarding these issues.

Interventional cardiology

Drug-Eluting Stents — The next chapter

1 COMMENT - Nov 1, 2006 11:00 EST

Drug-eluting stents (DESs) have become state of the art interventional therapy for the treatment of coronary vessel occlusion. To date, over 9 million DES devices have been placed. While DESs are designed to minimize the incidence of restenosis, late stent thrombosis appears to be problematic. This program will present the evolution of DES therapy, define late stent thrombosis, and describe current research that will take us to the next level with DES technology.

	Always
	Often
	Rarely
	Never